Weijun Ma

Statistics

Publications

Citations

752

H-Index

Active since

2004

Affiliations

Second Affiliated Hospital of Xi'an Jiaotong University(Current)

Pfizer (United States)

Ningxia University

Xi'an Jiaotong University

North Minzu University

Weijun Ma is an author at Second Affiliated Hospital of Xi'an Jiaotong University specializing in medicine, protein engineering, and antibody engineering.

ORCID

Publications per year

2004–2024

Publications

Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer

Wei Cao, Bilian Li, Peter LaPan et al. · Antibodies · 2016 · 95 citations · Full text

Pharmacy, Immunology, Medicinal Chemistry +17

Ginkgolide B protects against cisplatin-induced ototoxicity: enhancement of Akt–Nrf2–HO-1 signaling and reduction of NADPH oxidase

Weijun Ma, Juan Hu, Ying Cheng et al. · Cancer Chemotherapy and Pharmacology · 2015 · 66 citations

Medicine, Pharmacology, Toxicology +14

Modeling and mitigation of high-concentration antibody viscosity through structure-based computer-aided protein design

James R. Apgar, Amy Tam, Rhady Sorm et al. · PLoS ONE · 2020 · 52 citations · Full text

Pharmacy, Bioengineering, Pharmaceutics +17

Application of flexible fiberoptic bronchoscopy in the removal of adult airway foreign bodies

Weijun Ma, Juan Hu, Miaoli Yang et al. · BMC Surgery · 2020 · 48 citations · Full text

Medicine, Clinical Sciences, Surgery +11

Transient CHO expression platform for robust antibody production and its enhanced N‐glycan sialylation on therapeutic glycoproteins

Xiaotian Zhong, Weijun Ma, Caryl Meade et al. · Biotechnology Progress · 2018 · 46 citations

Life Sciences, Biochemistry, Biotechnology +16

1–5 of 28